5SX4
Crystal Structure of panitumumab in complex with epidermal growth factor receptor domain 3.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 5.0.2 |
| Synchrotron site | ALS |
| Beamline | 5.0.2 |
| Temperature [K] | 80 |
| Detector technology | CCD |
| Collection date | 2013-05-17 |
| Detector | ADSC QUANTUM 315 |
| Wavelength(s) | 1 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 65.273, 113.184, 232.443 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 29.596 - 2.800 |
| R-factor | 0.2255 |
| Rwork | 0.223 |
| R-free | 0.26610 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 1yy9 |
| RMSD bond length | 0.002 |
| RMSD bond angle | 0.485 |
| Data reduction software | HKL-2000 |
| Data scaling software | SCALEPACK |
| Phasing software | PHASER |
| Refinement software | PHENIX (dev_2356) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 30.000 | 30.000 | 2.900 |
| High resolution limit [Å] | 2.800 | 6.020 | 2.800 |
| Rmerge | 0.098 | 0.057 | 0.502 |
| Total number of observations | 261344 | ||
| Number of reflections | 43522 | ||
| <I/σ(I)> | 13.4 | ||
| Completeness [%] | 99.6 | 99.7 | 98.6 |
| Redundancy | 6 | 6.7 | 5.2 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 293 | 2.0 M AmSO4, 100 mM MES 6.5 and 5% peg 400 |






